Quick Answer
Scinai Immunotherapeutics Ltd. reported Shares Outstanding of 3.41 billion shares for fiscal year 2024.
Scinai Immunotherapeutics Ltd. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 3.41B | +83.7% |
| 2023 | 1.86B | +87.7% |
| 2022 | 989.29M | +33.9% |
| 2021 | 739.05M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| March 31, 2023 | 1.31B | — | +32.8% |
| December 31, 2022 | 989.29M | — | — |
- Scinai Immunotherapeutics Ltd. showed an increase of +83.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2021–2024 period, Scinai Immunotherapeutics Ltd.’s shares outstanding has grown by 361.7% (from 739.05 million shares to 3.41 billion shares).
- The most recent figure is from Scinai Immunotherapeutics Ltd.’s fiscal year 2024 report (Form 20-F), filed with the SEC on May 7, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: